The American Society of Clinical Oncology guideline program.
Winn
R F
RF
MD Anderson Cancer Center, University of Texas, Houston 77030, USA.
Smith
T F
TF
D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D005334:Fever / Q000139:chemically induced / Q000517:prevention & control / Q000628:therapy; D016179:Granulocyte Colony-Stimulating Factor / Q000627:therapeutic use; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000627:therapeutic use; D006801:Humans; D008495:Medical Oncology / Q000592:standards*; D009369:Neoplasms / Q000188:drug therapy*; D009503:Neutropenia / Q000139:chemically induced / Q000517:prevention & control / Q000628:therapy; D017410:Practice Guidelines as Topic; D012955:Societies, Medical; D016896:Treatment Outcome; D014481:United States